Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.8K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

588
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
588
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

1.0K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.0K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

1.4K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.4K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

2.1K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

621
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
621

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecularly Precise Triangular Termination of Kagome Covalent Organic Framework Crystals Enabled by Side-Chain Engineering.

Angewandte Chemie (International ed. in English)·2026
Same author

Combinatorial Design of Benzodithiophene-Benzothiadiazole Building Blocks for Ultralarge Pore Optoelectronically Tunable Covalent Organic Frameworks.

Journal of the American Chemical Society·2026
Same author

Band Gap Tuneability in Antiperovskite-Based Nitrides AE<sub>3</sub>PnN and Imides AE<sub>5</sub>Pn<sub>2</sub>(NH)<sub>2</sub> (AE = Ca, Sr; Pn = As, Sb, Bi).

Angewandte Chemie (International ed. in English)·2026
Same author

Covalent Organic Framework-Carbon Nanotube Core-Shell Nanohybrids for Enhanced Catalytic Site Utilization of Molecular Catalysts in CO<sub>2</sub> Electroreduction.

Angewandte Chemie (International ed. in English)·2026
Same author

Tuning Redox Behavior of Pyrene-Benzothiadiazole/TTF-Based Covalent Organic Framework Electrodes in Dual-Ion Batteries.

Angewandte Chemie (International ed. in English)·2026
Same author

The ontology of being ventilated-a less mechanistic and more holistic understanding.

Intensive care medicine·2026
Same journal

The evolution of nonoperating room anesthesia: navigating a new frontier.

Current opinion in anaesthesiology·2026
Same journal

Enhanced recovery pathways for patients with chronic pain: beyond standard protocols - a narrative review.

Current opinion in anaesthesiology·2026
Same journal

Novel technologies and innovations in postoperative follow-up after regional anesthesia.

Current opinion in anaesthesiology·2026
Same journal

Regional anaesthesia and analgesia in surgical patients with chronic preoperative pain: mechanisms, evidence, and clinical implications.

Current opinion in anaesthesiology·2026
Same journal

Retention in pain care and research: a narrative review focused on implanted medical devices.

Current opinion in anaesthesiology·2026
Same journal

Airway ultrasound in patients undergoing head and neck surgery.

Current opinion in anaesthesiology·2026
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

1.9K

Update on low-dose corticosteroids.

Josef Briegel1, Thomas Bein, Patrick Möhnle

  • 1aKlinik für Anästhesiologie, Klinikum der Universität München, Munich bKlinik für Anästhesiologie, Universitätsklinikum Regensburg, Regensburg, Germany.

Current Opinion in Anaesthesiology
|January 25, 2017
PubMed
Summary
This summary is machine-generated.

Low-dose corticosteroids (LDC) may improve outcomes in critically ill patients with severe systemic inflammation, particularly in acute respiratory distress syndrome and pneumonia. Further large-scale trials are needed to confirm survival benefits in septic shock.

More Related Videos

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

19.9K
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

1.1K

Related Experiment Videos

Last Updated: Mar 8, 2026

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

1.9K
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

19.9K
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

1.1K

Area of Science:

  • Critical care medicine
  • Pharmacology
  • Intensive care

Background:

  • Low-dose hydrocortisone is recommended for septic shock refractory to fluid and vasopressors.
  • Recent studies explore low-dose corticosteroids (LDC) in severe sepsis, ARDS, pneumonia, and burns.

Purpose of the Study:

  • To review and analyze recent findings on LDC in critically ill patients.
  • To comment on the efficacy of LDC in various critical conditions.

Main Methods:

  • Review of clinical trials and retrospective analyses published in the last two years.
  • Focus on LDC therapy in critically ill patients with severe systemic inflammation.

Main Results:

  • Morbidity improvements observed in acute respiratory distress syndrome (ARDS) and community-acquired pneumonia.
  • Retrospective analyses suggest potential survival benefits of LDC in severe septic shock and specific pneumonia/perforation cases.

Conclusions:

  • LDC therapy may enhance morbidity in select critically ill patient groups.
  • Demonstrating improved mortality requires large-scale randomized controlled trials.